seed
Stage
1
Investors
About
Kiwi Biosciences develops patent-pending enzyme supplements that break down FODMAP carbohydrates to reduce digestive symptoms in individuals with sensitive digestive systems.
Explore Kiwi Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.